Smart Shrinking Hydrogel Fights Infection and Rebuilds Wounds With a Flash of Light

Chronic, infected wounds remain one of the most stubborn problems in modern medicine, defeating ordinary gauze and sponge dressings that do little more than cover the damage. Now a research team writing in Materials Today Bio has unveiled a hydrogel that does far more than sit passively on a wound. The material, designated MPLG, actively contracts on demand under near-infrared light, squeezes out antibiotics exactly when infection flares, and then quietly feeds the healing tissue with regenerative magnesium ions. In infected wounds in rats, the dressing cleared bacteria and closed nearly 98 percent of the wound surface within two weeks.

The design tackles a fundamental tension in wound care. Photothermal therapy, in which light-absorbing nanoparticles heat tissue enough to rupture bacterial membranes, is a powerful antibacterial tool, but the same heat can destroy the delicate growth factors and proteins needed for tissue repair. The researchers solved this by building a material in which heat is not a side effect but a control signal: it triggers the hydrogel to shrink, and that shrinkage itself becomes the mechanism that times and delivers the drugs.

The hydrogel backbone is a copolymer network of gelatin methacryloyl (GelMA), N-isopropylacrylamide (NIPAM), and N-acryloyl glycinamide (NAGA), crosslinked in seconds by 395 nm ultraviolet light. GelMA contributes cell-adhesive motifs that bind integrin receptors on fibroblasts and endothelial cells, supporting proliferation and new blood vessel growth. NAGA was added to counter the brittleness of GelMA; through dense hydrogen bonding it toughens the network, and its polymer form exhibits an upper critical solution temperature that complements the lower critical solution temperature of roughly 32 degrees Celsius displayed by PNIPAM. This dual thermoresponsive architecture gives the material finer control over contraction than single-transition systems.

Embedded in this network are the true workhorses: core-shell nanoparticles made of magnesium coated with polydopamine and conjugated with the fluoroquinolone antibiotic levofloxacin. X-ray photoelectron spectroscopy revealed a striking chemical detail, an interfacial magnesium-fluorine bond that anchors the drug to the particle surface. That bond is acid-sensitive, which matters because infected wounds are typically more acidic than healthy tissue. In the acidic, irradiated environment of an early infection, polydopamine degrades and levofloxacin pours out to halt bacterial DNA replication; as conditions later neutralize, release slows to a sustained trickle of magnesium ions suited to regeneration rather than killing.

The light-triggered mechanics are equally precise. Under 808 nm near-infrared irradiation at 2.0 watts per square centimeter, the polydopamine nanoparticles heat the hydrogel to roughly 45 to 48 degrees Celsius within minutes, pushing it past its phase-transition temperature of about 34 degrees. The network collapses, shrinking in volume by more than 35 percent, and this contraction mechanically drives out the payload. The team quantified the link rigorously: Pearson correlation analysis showed that early-stage release increments of both levofloxacin and magnesium tracked volume shrinkage with coefficients of determination above 0.95. At body temperature without light, passive leakage stayed below 5 percent over 24 hours, meaning the dressing keeps its cargo locked until commanded otherwise.

That command proved devastating to bacteria. Against Escherichia coli and Staphylococcus aureus, the illuminated composite hydrogel reduced viable colony counts by factors of 332 and 212 respectively, far outperforming free antibiotic or heat alone. Scanning electron micrographs showed collapsed membranes and leaked intracellular contents, evidence of the dual mechanism in which photothermal heating disrupts bacterial envelopes while released levofloxacin blocks replication. Crystal violet assays revealed the same hierarchy against biofilms, the slimy bacterial fortresses that chronically resist both immune clearance and antibiotics. The authors note that combining physical and chemical killing may also reduce the selection pressure that drives antibiotic resistance, allowing effective treatment at lower drug doses.

Beyond sterilization, the material actively reshapes the wound’s immunological and vascular landscape. Sustained magnesium release pushed inflammatory M1 macrophages toward the healing-associated M2 phenotype, an effect amplified by mild photothermal stimulation, while polydopamine mopped up the reactive oxygen species that would otherwise sabotage angiogenic signaling. Under oxidative stress mimicking a pathological wound bed, endothelial cells treated with the illuminated hydrogel showed near-complete ROS clearance, robust proliferation, and markedly enhanced tube formation and migration. Macrophage migration reached 86.7 percent within 24 hours, the highest of any tested condition, supporting a swift transition from inflammation to tissue building.

The in vivo results were the most striking. In rats with Staphylococcus aureus-infected full-thickness skin defects, the precursor solution was injected into the wound bed and gelled in place under brief ultraviolet exposure, then irradiated on three consecutive days. Thermal imaging confirmed the hydrogel reached approximately 47 degrees at the wound surface, while histology and TUNEL staining showed no thermal injury to the surrounding tissue. Bacterial burden in the wounds fell roughly 27-fold compared with untreated controls. Wound area shrank by 57 percent at day 3, 73 percent at day 7, and 98.4 percent by day 14, with the hydrogel degrading almost completely in step with tissue regrowth.

Microscopic analysis of healed tissue told the deeper story of why the treated wounds fared better. The MPLG group showed continuous epidermis, the lowest scar index, and well-aligned, densely packed collagen fibers. Immunofluorescence revealed a shift from M1 to M2 macrophage markers, elevated CD31 signaling new blood vessel formation, increased Ki67-driven proliferation, and a maturing collagen profile in which strong type I collagen replaced the provisional type III network. Blood counts, serum chemistry, hemolysis rates, and organ histology all remained normal, indicating the material and its light treatment are well tolerated systemically.

The authors are candid about the road to the clinic. Deep ultraviolet gelation penetrates less than a centimeter of tissue, a limitation for irregular or heavily exuding wounds, and the long-term safety of repeated near-infrared heating in diabetic or ischemic wounds remains unproven. Scaling the multistep nanoparticle synthesis under good manufacturing practice will also demand careful batch control. Still, the modular concept, a dressing that physically pulls wound edges together while releasing the right drug at the right moment, could extend beyond skin to burns and diabetic ulcers, marking a shift from dressings that merely protect wounds to materials that actively run the healing program.

Subject of Research: A near-infrared-responsive contractile hydrogel with core-shell nanoparticles for programmed antibacterial and pro-angiogenic wound healing

Article Title: Contractile hydrogel with NIR-induced spatiotemporally programmed release from core-shell nanoparticles for integrated antibacterial and pro-angiogenic healing

Article References: Zhang, M. J., Song, J., Song, X., Zhang, A., XI, H., & Xin, L. (2026). Contractile hydrogel with NIR-induced spatiotemporally programmed release from core-shell nanoparticles for integrated antibacterial and pro-angiogenic healing. Materials Today Bio, 41, Article 103713. https://doi.org/10.1016/j.mtbio.2026.103713

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103713

Keywords: hydrogel, wound healing, photothermal therapy, near-infrared, levofloxacin, polydopamine, magnesium ions, antibacterial, biofilm, angiogenesis, macrophage polarization, drug release